Citigroup’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-18,000	Closed	-$7K	–	5826
2022 Q2	$7K	Buy	18,000 +10,600	+143%	+$4.12K	﹤0.01%	4769
2022 Q1	$11K	Buy	+7,400	New	+$11K	﹤0.01%	4720